Skip to main content

Advertisement

Table 1 Prevalence of CHEK2 1100delC in sporadic and familial breast cancer and controls

From: CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer

  CHEK2 1100delC+/total tested p-value1
Familial Risk Cohort 6/311 (1.9%) 0.09
Population-based Cohort 5/452 (1.1%) 0.51
   Sporadic breast cancer 1/313 (0.3%) 0.68
   Familial Breast Cancer 4/139 (2.9%) 0.04
All Familial patients 10/450 (2.2%) 0.03
Controls 5/760 (0.7%)  
  1. 1P-values were calculated with Fisher's test for association